CONMED CNMD G&A
G&A at other companies
Other financials
Where this comes from
Reported directly by CONMED in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about CONMED's g&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is CONMED's G&A?
- CONMED (CNMD) reported G&A of $32.4M in Q1 2026.
- How has CONMED's G&A changed year-over-year?
- CONMED's G&A decreased by 0.8% year-over-year, from $32.66M to $32.4M.
- What is the long-term trend for CONMED's G&A?
- Over 3 years (2022 to 2025), CONMED's G&A has grown at a 11.1% compound annual growth rate (CAGR), from $96.11M to $131.97M.
- What does G&A mean?
- Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.